Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin.
Male
Muscle, Smooth, Vascular/ cytology/drug effects/enzymology
0303 health sciences
Cell Division/drug effects
Heparin
info:eu-repo/classification/ddc/616.07
Actins/ biosynthesis/genetics
Cell Cycle
Rats, Inbred Strains
Cell Separation
ddc:616.07
Blotting, Northern
Actins
Muscle, Smooth, Vascular
Rats
3. Good health
03 medical and health sciences
RNA/isolation & purification
Heparin/ pharmacology
Animals
RNA
Electrophoresis, Polyacrylamide Gel
Cell Division
DOI:
10.1083/jcb.107.5.1939
Publication Date:
2004-05-15T00:18:20Z
AUTHORS (6)
ABSTRACT
Quiescent smooth muscle cells (SMC) in normal artery express a pattern of actin isoforms with alpha-smooth (alpha SM) predominance that switches to beta when the are proliferating. We have examined relationship between change and entry SMC into growth cycle an vivo model proliferation (balloon injured rat carotid artery). alpha SM mRNA declined cytoplasmic (beta + gamma) mRNAs increased early G0/G1 (between 1 8 h after injury). In synthesis vitro translation experiments demonstrated functional is decreased 24 injury proportional amount present. At 36 injury, prepared by enzymatic digestion were sorted S/G2 populations; only committed proliferate (S/G2 fraction) showed relative slight decrease and, more importantly, large mRNA. A switch from was present whole population 5 d injury. To determine if associated proliferation, we inhibited approximately 80% heparin, which has previously been shown block late reduce fraction. The at not prevented; however, protein reinduced heparin-treated animals compared saline-treated controls. These results suggest arterial depends on levels changes whether or subsequently proliferate. prevented but they eventually reversed kept resting state heparin treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (108)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....